Brian Gormley

Health Care Reporter, The Wall Street Journal, The Wall Street Journal - Venture Capital Dispatch

Preston's Summary

Brian Gormley is a Health Care Reporter for The Wall Street Journal and The Wall Street Journal - Venture Capital Dispatch. With a focus on the intersection of healthcare and finance, Brian covers topics such as biotech investments, medical innovations, and venture funding in the healthcare sector. His work has also been featured in Nature Portfolio, Private Equity News, Financial News, and Yahoo Finance.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

International

Coverage Attributes:

Beta
Press Release: 37 %
Private Sector Announcements: 36 %
Industry Specific: 13 %
Investment Analysis: 6 %
Cites Data: 3 %

Themes Covered:

Most Recent Topics:

  • Biotech
  • Venture Funding
  • Healthcare
  • Startups
  • Venture Capital

Pitching Insights

Brian Gormley's coverage spans across biotech, venture funding, healthcare, startups and venture capital within the business sphere. His articles often feature private sector announcements and press releases. Therefore, he would be most receptive to pitches that involve exclusive access to new developments in the biotech or healthcare industry, particularly those related to startup launches, venture funding rounds or major partnerships within these sectors.

Given his focus on private sector announcements and industry-specific content, Brian may find great value in sources who can provide detailed insights into specific companies' strategies or market moves within the mentioned industries. If you have unique data analysis related to trends in biotechnology startups or healthcare investment landscape it could garner his interest.

Since Brian doesn't seem to have a geographic focus specified but covers international investments as well as local ones from different countries such as Saudi Arabia and United States among others; relevant news concerning global events can also be pitched effectively given its relevance with aspects covered by him such as start-ups ventures etc.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Andrew Dunn
Biopharma Correspondent
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Scientific, Health & Wellbeing, Sales & Marketing
Most recent topics
Biotechnology, Healthcare & Pharmaceutical, Real Estate Industry
Most recent topics
Healthcare & Pharmaceutical, Software & SaaS, Big Tech, Business, Health
Publications
Most recent topics
Healthcare & Pharmaceutical, Biotechnology, Business, Health, Product Promotions
Most recent topics
Business, Business & Industry, Healthcare & Pharmaceutical, Big Tech, Tech
Most recent topics
Healthcare & Pharmaceutical, Finance & Economy, Sales & Marketing, Scientific, Biotechnology